| Trial ID: | L6238 |
| Source ID: | NCT01357109
|
| Associated Drug: |
Bosentan
|
| Title: |
Effect of Bosentan on Endothelial Function in Patients With Type 2 Diabetes
|
| Acronym: |
BANDY
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: Bosentan|DRUG: Placebo
|
| Outcome Measures: |
Primary: Peripheral endothelial function, 4 weeks | Secondary: Inflammatory markers, 4 weeks|Renal protein excretion, 4 weeks|Myocardial perfusion, 4 weeks
|
| Sponsor/Collaborators: |
Sponsor: Karolinska Institutet | Collaborators: Swedish Heart Lung Foundation|The Swedish Research Council|Actelion
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
56
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2007-11
|
| Completion Date: |
2011-01
|
| Results First Posted: |
|
| Last Update Posted: |
2011-05-20
|
| Locations: |
Karolinska Institutet, Karolinska University Hospital, Stockholm, 17176, Sweden
|
| URL: |
https://clinicaltrials.gov/show/NCT01357109
|
